Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Accuray
 | |
| Company type | Public company |
|---|---|
| Nasdaq: ARAY | |
| Founded | 1992 |
| Founder | John R. Adler |
| Headquarters | Madison, Wisconsin , United States |
| Products | CyberKnife, tomotherapy |
Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).[1] It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform.[2] The company is headquartered in Sunnyvale, CA, the United States.[3] The platforms are installed in leading healthcare centres in approximately 50 countries globally.
- ^ "Accuray Is A Promising Radiation Oncology Buy In 2018 (NASDAQ:ARAY) | Seeking Alpha". seekingalpha.com. November 16, 2018. Retrieved January 9, 2023.
- ^ "Accuray Incorporated : Annual Report for Fiscal Year Ending --06-30, 2022 (Form 10-K)". August 17, 2022.
- ^ Saul, Stephanie (December 17, 2008). "Geography Has Role in Medicare Cancer Coverage". The New York Times. ISSN 0362-4331. Retrieved January 9, 2023.
Previous Page Next Page
